Joint Formulary & PAD

Pyrazinamide - Tuberculosis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Not Specified
Associated Icons :
BNF SPC
R
Restrictions / Comments :
Important
Liaise with Chest Physician. Patients with multi-drug resistant TB should be treated by a specialist centre.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Pyrazinamide
Indication :
Tuberculosis
Group Name :
Keywords :
antibiotic, antibacterial, TB
Brand Names Include :
Rifater
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Pyrazinamide is used to treat.

  • No records returned.

Committee Recommendations (1)

01 Sep 07 - Not Set
September 2007 – The DH changed the regulations and advice relating to the treatment of TB. Patients requiring TB medication should be treated in specialist TB clinics where they will not be subject to prescription charges. FP10 prescriptions are not exempt from charges and should not be used.